Angola vs Eastern Mediterranean (WHO region): Number of pregnant women living with HIV who received antiretrovirals
Angola
22,443
in 2025
Eastern Mediterranean (WHO region)
2,100
in 2025
Angola rank
10th
Eastern Mediterranean (WHO region) rank
7th
Number of pregnant women living with HIV who received antiretrovirals over time
- Angola
- Eastern Mediterranean (WHO region)
How they compare
Angola currently reports 22,443 against 2,100 in Eastern Mediterranean (WHO region), a difference of 20,343.
That makes Angola's figure about 10.7 times Eastern Mediterranean (WHO region)'s.
Across all 16 years both countries report, Angola has been ahead every year.
Angola ranks 10th and Eastern Mediterranean (WHO region) ranks 7th of 115 countries.
Angola has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Eastern Mediterranean (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7,169 | 874 | 6,295 | Angola |
| 2020s | 19,980 | 1,517 | 18,463 | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of pregnant women living with hiv who received antiretrovirals, Angola or Eastern Mediterranean (WHO region)?
- Angola, at 22,443 against 2,100 in Eastern Mediterranean (WHO region) as of 2025.
- What is the difference in number of pregnant women living with hiv who received antiretrovirals between Angola and Eastern Mediterranean (WHO region)?
- 20,343, with Angola ahead.
- How many years of comparable data are there for Angola and Eastern Mediterranean (WHO region)?
- 16 years are reported by both, from 2010 to 2025.
- How do Angola and Eastern Mediterranean (WHO region) rank globally for number of pregnant women living with hiv who received antiretrovirals?
- Angola ranks 10th and Eastern Mediterranean (WHO region) ranks 7th of 115 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission. Statizoid refreshes it automatically from the source and publishes the full history for both places.